Detalhe da pesquisa
1.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577874
2.
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654658
3.
Successful Allogeneic Peripheral Blood Stem Cell Transplantation in 4 Wiskott-Aldrich Syndrome Patients.
J Pediatr Hematol Oncol
; 44(2): e324-e328, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828030
4.
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(2): 209-218, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119152
5.
Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria.
Ann Hematol
; 99(3): 619-625, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974679
6.
Peripheral Blood Stem Cell Mobilization and Collection in Pediatric Healthy Sibling Donors Weighing 20 Kilograms or Less; Algerian Experience.
Transfus Apher Sci
; 59(6): 102987, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33162340
7.
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
Biol Blood Marrow Transplant
; 25(12): 2330-2337, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002990
8.
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working party.
Am J Hematol
; 94(1): 80-86, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30328134
9.
Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(4): 751-757, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247780
10.
Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 23(3): 467-474, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27916512
11.
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(6): 1054-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25708221
12.
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.
Haematologica
; 100(5): 696-702, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616576
13.
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study.
Blood
; 119(12): 2935-42, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22160619
14.
Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow Transplantation.
Haematologica
; 104(8): e335-e339, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679331
15.
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant
; 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615143
16.
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant
; 59(4): 526-533, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297040
17.
Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP.
Bone Marrow Transplant
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627449
18.
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant
; 58(3): 282-287, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460819
19.
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).
Bone Marrow Transplant
; 58(10): 1084-1088, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37420011
20.
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Haematologica
; 97(8): 1142-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315497